Welcome to LookChem.com Sign In|Join Free

CAS

  • or

298708-79-9

Post Buying Request

298708-79-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

298708-79-9 Usage

Description

BAY41-4109 Racemic, also known as 4-(2-chloro-4-fluorophenyl)-2-(3,5-difluoro-2-pyridinyl)-1,4-dihydro-6-methyl-5-pyrimidinecarboxylic Acid Methyl Ester, is an antiviral compound with potent activity against Hepatitis B Virus (HBV). It functions by inhibiting HBV replication through the destabilization of capsid assembly, making it a promising candidate for the treatment of HBV infections.

Uses

Used in Pharmaceutical Industry:
BAY41-4109 Racemic is used as an antiviral agent for the treatment of Hepatitis B Virus (HBV) infections. It targets the viral replication process by destabilizing the capsid assembly, which is crucial for the virus's ability to replicate and spread within the host.
Additionally, BAY41-4109 Racemic may be used as a research tool in the study of HBV replication mechanisms and the development of novel antiviral therapies. Its potent activity against HBV makes it a valuable compound for understanding the virus's life cycle and identifying potential therapeutic targets.

Check Digit Verification of cas no

The CAS Registry Mumber 298708-79-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,9,8,7,0 and 8 respectively; the second part has 2 digits, 7 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 298708-79:
(8*2)+(7*9)+(6*8)+(5*7)+(4*0)+(3*8)+(2*7)+(1*9)=209
209 % 10 = 9
So 298708-79-9 is a valid CAS Registry Number.

298708-79-9Relevant articles and documents

HETEROARYLDIHYDROPYRIMIDINE DERIVATIVES AND METHODS OF TREATING HEPATITIS B INFECTIONS

-

Page/Page column 32-33; 43, (2021/06/26)

Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.

Medicaments against viral diseases

-

Page 10, (2010/02/05)

Novel dihydropyrimidines and combinations thereof with other antiviral agents, suitable for combating HBV infections.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 298708-79-9